Last reviewed · How we verify

NCT06183060

Study on the Decision Support System of Difficult Airway Evaluation

Status unknown Last updated 27 December 2023
What this trial tests

trial testing endotracheal intubation in Difficult Airway in 1,000 participants. Status unknown.

Timeline
21 March 2022
Primary endpoint
31 December 2025
31 March 2026

Quick facts

Lead sponsorPeking University Third Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date21 March 2022
Primary completion31 December 2025
Estimated completion31 March 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University Third Hospital

Who can join

Adults 20 to 80, any sex, with Difficult Airway. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on the evaluation of preoperative physical indicators and radiologic indicators of cervical surgery, this study puts forward effective indicators for predicting difficult airway before operation, and establishes a comprehensive decision support system of difficult airway evaluation, so as to provide a theoretical basis for the early warning of difficult airway before cervical spondylosis surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of endotracheal intubation

Trials testing the same drug.

Other recruiting trials for Difficult Airway

Currently open trials in the same condition.

Other Peking University Third Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06183060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing